Ecosystems And Livelihoods Adaptation Network (Elan)Edward Cameron
This presentation was delivered to the Ecosystem and Livelihoods Adaptation Network (ELAN) Working Group in Buenos Aires in August 2009. ELAN is a joint initiative of WWF and IUCN
JavaScript Debugging Tips and Tricks @CSharpcorner Delhi Chapter - 5th Sep 2015.
We discussed the common pitfalls every JavaScript Developer get into and how to debug those mis-takes!
Ecosystems And Livelihoods Adaptation Network (Elan)Edward Cameron
This presentation was delivered to the Ecosystem and Livelihoods Adaptation Network (ELAN) Working Group in Buenos Aires in August 2009. ELAN is a joint initiative of WWF and IUCN
JavaScript Debugging Tips and Tricks @CSharpcorner Delhi Chapter - 5th Sep 2015.
We discussed the common pitfalls every JavaScript Developer get into and how to debug those mis-takes!
Corporate training - Mind Programming - Kushalta AcademyJohn Bhatt
Kushalta Academy is a venture of LSTT offering professional and life enhancing skill development courses to needy under government schemes. Mind Programming is one of main skill training of Kushalta Academy.
Large organisations large intranets: where to start a redevelopment projectTamsin Stanford
No matter where you sit in a large organisation, it can be a daunting task to start a redevelopment project, particularly if you are new to the organisation and don’t have existing networks. In this presentation, Tamsin shares tips and insights – the why and the how – from working for two of Australia’s most iconic brands:
1. The importance of ensuring your executives are on board, and how to convince them
2. How and why to build an unofficial project team
3. Starting small to achieve big results (ANZ case study)
Corporate training - Mind Programming - Kushalta AcademyJohn Bhatt
Kushalta Academy is a venture of LSTT offering professional and life enhancing skill development courses to needy under government schemes. Mind Programming is one of main skill training of Kushalta Academy.
Large organisations large intranets: where to start a redevelopment projectTamsin Stanford
No matter where you sit in a large organisation, it can be a daunting task to start a redevelopment project, particularly if you are new to the organisation and don’t have existing networks. In this presentation, Tamsin shares tips and insights – the why and the how – from working for two of Australia’s most iconic brands:
1. The importance of ensuring your executives are on board, and how to convince them
2. How and why to build an unofficial project team
3. Starting small to achieve big results (ANZ case study)
Evaluating Teaching: SECTIONS.
Check out:
Bates, A. W., & Poole, G. (2003). Effective Teaching with Technology in Higher Education: Foundations for Success. Jossey-Bass, An Imprint of Wiley. 10475 Crosspoint Blvd, Indianapolis, IN 46256.
Evaluating Teaching: Anstey and Watson Rubric
Check out:
Lauren M. Anstey & Gavan P.L. Watson. (2018), Rubric for eLearning Tool Evaluation. Centre for Teaching and Learning, Western University,
http://creativecommons.org/licenses/by-n c-sa/4.0/
Designing Teaching: ASSURE
Check out:
Heinich, R., Molenda, M., & Russell, J. D., (1993). Instructional Media and The New
Technologies of Instruction. New York: Macmillan
Designing Teaching: Laurilliard's Learning TypesDamian T. Gordon
Designing Teaching: Laurilliard's Learning Types
Check out:
Laurillard, D., 2013. Teaching as a design science: Building pedagogical patterns for learning and technology. Routledge.
Designing Teaching: Elaboration Theory
Check out:
Reigeluth, C. & Stein, F. (1983). The elaboration theory of instruction. In C. Reigeluth (ed.), Instructional Design Theories and Models. Hillsdale, NJ: Erlbaum Associates.
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...NelTorrente
In this research, it concludes that while the readiness of teachers in Caloocan City to implement the MATATAG Curriculum is generally positive, targeted efforts in professional development, resource distribution, support networks, and comprehensive preparation can address the existing gaps and ensure successful curriculum implementation.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.
How to Add Chatter in the odoo 17 ERP ModuleCeline George
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
7. Prescription Dr. Lewis Zimmerman 459 Patient name: Tom Paris Stardate: 41153.7 Drug: Tri-Ox Compound Take twice a day Dr. Lewis Zimmerman 459 Patient name: Tom Paris Stardate: 41153.7 Drug: Tri-Ox Compound Take twice a day
8. Prescription Dr. Lewis Zimmerman 459 Patient name: Tom Paris Stardate: 41153.7 Drug: Tri-Ox Compound Take twice a day Doctor Patient Date Drug Frequency Prescription number Dr. Lewis Zimmerman 459 Patient name: Tom Paris Stardate: 41153.7 Drug: Tri-Ox Compound Take twice a day
11. Prescription 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L. Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman 1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
12.
13.
14.
15. Prescription 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L. Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman 1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
16. Prescription 3 37389.5 Tri-Ox T’Pol 4 9 4 45673.4 Hyronalin Katherine Janeway 1 8 5 42604.4 Tri-Ox Tom Paris 1 7 90 42765.5 Priaxate Tom Paris 1 6 2 48796.6 Synaptizine Odo 2 5 1 45912.3 Hyronalin Lt. Data 2 4 7 42235.2 Tri-Ox Harry Kim 1 3 3 45432.1 Hyronalin Odo 2 2 2 42231.2 Tri-Ox Tom Paris 1 1 Frequency (per day) Date Drug Name Patient Name Doctor ID Prescription ID
17.
18. Prescription 3 37389.5 Tri-Ox T’Pol 4 9 4 45673.4 Hyronalin Katherine Janeway 1 8 5 42604.4 Tri-Ox Tom Paris 1 7 90 42765.5 Priaxate Tom Paris 1 6 2 48796.6 Synaptizine Odo 2 5 1 45912.3 Hyronalin Lt. Data 2 4 7 42235.2 Tri-Ox Harry Kim 1 3 3 45432.1 Hyronalin Odo 2 2 2 42231.2 Tri-Ox Tom Paris 1 1 Frequency (per day) Date Drug Name Patient Name Doctor ID Prescription ID
19. Prescription 3 37389.5 Tri-Ox 6 4 9 4 45673.4 Hyronalin 5 1 8 5 42604.4 Tri-Ox 1 1 7 90 42765.5 Priaxate 1 1 6 2 48796.6 Synaptizine 2 2 5 1 45912.3 Hyronalin 4 2 4 7 42235.2 Tri-Ox 3 1 3 3 45432.1 Hyronalin 2 2 2 2 42231.2 Tri-Ox 1 1 1 Frequency (per day) Date Drug Name Patient ID Doctor ID Prescription ID
20.
21. Prescription 3 37389.5 Tri-Ox 6 4 9 4 45673.4 Hyronalin 5 1 8 5 42604.4 Tri-Ox 1 1 7 90 42765.5 Priaxate 1 1 6 2 48796.6 Synaptizine 2 2 5 1 45912.3 Hyronalin 4 2 4 7 42235.2 Tri-Ox 3 1 3 3 45432.1 Hyronalin 2 2 2 2 42231.2 Tri-Ox 1 1 1 Frequency (per day) Date Drug Name Patient ID Doctor ID Prescription ID
22. Prescription 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID
23.
24. Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
27. Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
28. Prescription Drug Patient Doctor Text Numbers Text Text 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
29. Prescription Drug Patient Doctor Transactional Table Master Table Master Table Master Table 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
30.
31. Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
32. Prescription Drug Patient Doctor Tricordrazine 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID
33.
34. Prescription 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L. Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman 1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
35. Prescription Tricordrazine Tricordrazine Tricordrazine Tricordrazine 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L. Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman 1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
36.
37. Prescription Tricordrazine Tricordrazine Tricordrazine 3 37389.5 Tri-Ox T’Pol Dr. Phlox 9 4 45673.4 Hyronalin Katherine Janeway Dr. L. Zimmerman 8 5 42604.4 Tri-Ox Tom Paris Dr. Lewis Zimmerman 7 90 42765.5 Priaxate Tom Paris L. Zimmerman 6 2 48796.6 Synaptizine Odo Dr. Bashir 5 1 45912.3 Hyronalin Lt. Data Dr. Beverly Crusher 4 7 42235.2 Tri-Ox Harry Kim Lewis Zimmerman 3 3 45432.1 Hyronalin Odo Dr. Julian Bashir 2 2 42231.2 Tri-Ox Tom Paris Dr. Lewis Zimmerman 1 Frequency (per day) Date Drug Name Patient Name Doctor Name Prescription ID
38.
39.
40. Prescription Drug Patient Doctor 3 37389.5 1 6 4 9 4 45673.4 2 5 1 8 5 42604.4 1 1 1 7 90 42765.5 4 1 1 6 2 48796.6 3 2 2 5 1 45912.3 2 4 2 4 7 42235.2 1 3 1 3 3 45432.1 2 2 2 2 2 42231.2 1 1 1 1 Frequency (per day) Date Drug ID Patient ID Doctor ID Prescription ID Priaxate 4 Synaptizine 3 Hyronalin 2 Tri-Ox 1 Drug Name Drug ID T’Pol 6 Katherine Janeway 5 Lt. Data 4 Harry Kim 3 Odo 2 Tom Paris 1 Patient Name Prescription ID Dr. Phlox 4 Dr. Beverly Crusher 3 Dr. Julian Bashir 2 Dr. Lewis Zimmerman 1 Doctor Name Doctor ID